The future of engineered immune cell therapies.

The future of engineered immune cell therapies.
复制标题

DOI:
10.1126/science.abq6990
复制
发表时间:
2022-11-25
期刊:
Science (New York, N.Y.)
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

免疫细胞正在被改造成能够识别疾病状态并对其做出反应,当转移到患者体内时,它就像一种“活药物”。基于工程化免疫细胞的疗法现在已成为临床现实,多种工程化T细胞疗法已被批准用于治疗血液恶性肿瘤。正在进行的临床前和临床研究正在测试多种策略,以改变免疫细胞的命运和功能,用于癌症,传染病等。我们讨论了目前在用免疫细胞疗法治疗人类疾病方面的进展,免疫细胞工程的新兴策略以及该领域面临的挑战,特别强调了迄今为止最努力的癌症治疗。
Immune cells are being engineered to recognize and respond to disease states, acting as a “living drug” when transferred into patients. Therapies based on engineered immune cells are now a clinical reality, with multiple engineered T cell therapies approved for treatment of hematologic malignancies. Ongoing preclinical and clinical studies are testing diverse strategies to modify the fate and function of immune cells for applications in cancer, infectious disease, and beyond. We discuss current progress in treating human disease with immune cell therapeutics, emerging strategies for immune cell engineering, and challenges facing the field, with a particular emphasis on the treatment of cancer, where the most effort has been applied to date.
DOI: 10.1038/nchembio.2565
发表时间: 2018-03
影响因子: 14.8
作者:
Chang ZL;Lorenzini MH;Chen X;Tran U;Bangayan NJ;Chen YY
通讯作者: Chen YY
DOI: 10.1126/scitranslmed.abb6295
发表时间: 2021-01-06
影响因子: 17.1
作者:
Jan M;Scarfò I;Larson RC;Walker A;Schmidts A;Guirguis AA;Gasser JA;Słabicki M;Bouffard AA;Castano AP;Kann MC;Cabral ML;Tepper A;Grinshpun DE;Sperling AS;Kyung T;Sievers QL;Birnbaum ME;Maus MV;Ebert BL
通讯作者: Ebert BL
DOI: 10.1038/s41591-021-01497-1
发表时间: 2021-10
期刊: Nature medicine
影响因子: 82.9
作者:
Cordoba S;Onuoha S;Thomas S;Pignataro DS;Hough R;Ghorashian S;Vora A;Bonney D;Veys P;Rao K;Lucchini G;Chiesa R;Chu J;Clark L;Fung MM;Smith K;Peticone C;Al-Hajj M;Baldan V;Ferrari M;Srivastava S;Jha R;Arce Vargas F;Duffy K;Day W;Virgo P;Wheeler L;Hancock J;Farzaneh F;Domning S;Zhang Y;Khokhar NZ;Peddareddigari VGR;Wynn R;Pule M;Amrolia PJ
通讯作者: Amrolia PJ
DOI: 10.1016/j.cels.2020.08.002
发表时间: 2020-09-23
期刊: Cell systems
影响因子: 9.3
作者:
Dannenfelser R;Allen GM;VanderSluis B;Koegel AK;Levinson S;Stark SR;Yao V;Tadych A;Troyanskaya OG;Lim WA
通讯作者: Lim WA
DOI: 10.1038/s41577-019-0269-6
发表时间: 2020-05
期刊: Nature reviews. Immunology
影响因子: --
作者:
Irvine DJ;Dane EL
通讯作者: Dane EL